Autolus, a biopharmaceutical company based in the United Kingdom, plans to create a new U.S. headquarters in Rockville, creating about 170 jobs by 2021. The company discovers and develops cancer treatments using T-cell programming and manufacturing. “Autolus is delighted to ...

Tagged with: Autolus biopharmaceutical

A Gaithersburg biopharmaceutical company has raised $23 million in Series A financing, the company announced Tuesday. NexImmune raised the money in a round co-led by ArrowMark Partners and Barer & Son, along with participation from Piedmont Capital Partners. ArrowMark is ...

Tagged with: biopharmaceutical funding NexImmune series A

Medicinal botanical company Vitreon America announced Monday it plans to move its corporate headquarters to Baltimore from Virginia, creating 200 full-time jobs over the next five years. In addition to its new headquarters on Wicomico Street, the company also indicated it ...

Tagged with: biopharmaceutical morgan state university tax credits Vitreon

GlycoMimetics Inc., of Gaithersburg, a biopharmaceutical company focused on discovering and developing drugs for human wound healing and tissue repair, said it has received a $15 million payment from Pfizer Inc., under a collaborative agreement between the two companies for the development of rivipansel, a treatment for painful episodic flare-ups of sickle cell disease.

Tagged with: biopharmaceutical maryland medicine

FREDERICK — A new study authored by Army scientists at Fort Detrick reports that a treatment grown in tobacco plants cured three of seven monkeys that developed symptoms from the deadly Ebola virus. The Frederick News-Post reports the treatment, called ...

Tagged with: biopharmaceutical ebola fort detrick treatment

Cerecor Inc., of Baltimore, a biopharmaceutical company focused on developing and commercializing prescription drugs involving the human nervous system, said it has acquired from Merck & Co. the exclusive, worldwide rights to a drug called MK-0657, which it said has the potential to treat depression. Merck originally developed MK-0657 for treatment of Parkinson’s disease.

Tagged with: biopharmaceutical biotechnology merck

David Parkinson, M.D., has been appointed to the board of directors of Zyngenia Inc., a Gaithersburg-based biopharmaceutical company, and named head of its clinical advisory board. He will also serve as interim chief medical officer. From 2007 until 2012, Parkinson ...

Tagged with: biopharmaceutical biotech food and drug administration oncology

FREDERICK — The biopharmaceutical company MedImmune is expanding its Frederick manufacturing plant. Frederick city and county officials joined the company in celebrating the official opening Friday of a 337,000-square-foot addition. The new space expands production capacity for products including Synagis, ...

Tagged with: biopharmaceutical frederick gaithersburg london maryland medimmune virus

Vanda Pharmaceuticals Inc. of Rockville, a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, announced an exclusive licensing agreement with Probiomed S.A. de C.V., a wholly owned pharmaceutical operating unit of Proquifin S.A. ...

Tagged with: biopharmaceutical company maryland Mexico rockville

BETHESDA — Cancer drug developer Micromet Inc. on Tuesday named Ulrich Grau, a biopharmaceutical industry veteran, as its executive vice president and chief operating officer, effective immediately. Grau has more than 30 years of experience in operations and research and ...

Tagged with: bethesda biopharmaceutical biotechnology chief operating officer pharmaceutical